Factors Affecting the Surgical Level of Major Amputations in Patients with Severe Diabetic Foot

LI Yi-hui, QIAN Zhi-feng, LI Li-yi, LI Tai-shun, WANG Hai-lin, SHU Chang, LIANG Yong, WANG Ai-ping

Abstract

To investigate the main factors affecting the surgical level of major amputations in patients with severe diabetic foot.   Methods  A case-control study was conducted to analyze the clinical data of severe diabetic foot patients who had major amputations and were admitted to the Intensive Care Unit (ICU), Air Force Hospital of PLA Eastern Theater Command between July 2020 and July 2022. According to their surgical level of amputation, patients were divided into transtibial amputation (TT) group and transfemoral amputation (TF) group. Correlation analysis was performed with the clinical data of the patients, and multivariate logistic regression was performed to screen for relevant factors affecting the surgical level of major amputation.   Results  The data of 48 patients with major amputations were collected, including 15 patients in the TT group and 33 patients in the TF group. The proportion of patients who had cardiovascular and cerebrovascular complications in the TT group was lower than that in the TF group (26.67% [4/15] vs. 57.58% [19/33], P<0.05), the proportion of patients who had lower extremity arterial intervention history was higher in the TT group than that in the TF group (40% [6/15] vs. 9.09% [3/33], P<0.05), and the proportion of patients who had elevated creatinine level was lower in the TT group than that in the TF group (70.31±22.98 vs. 127.98±108.38, P<0.05). Moreover, the history of lower extremity arterial intervention may be an independent protective factor for determining the surgical level of major amputations (odds ratio [OR]=0.15, 95% confidence interval [CI]: 0.03-0.72, P=0.018).   Conclusion  History of cardiovascular and cerebrovascular diseases, serum creatinine level and history of lower extremity arterial intervention are the main factors affecting the surgical level of major amputations in patients with severe diabetic foot, and the history of lower extremity arterial intervention may be an independent protective factor.

 

Keywords: Diabetic foot, Major amputation, The history of lower extremity arterial intervention

 

Full Text:

PDF


References


VAN NETTEN J J， BUS S A， APELQVIST J， et al. Definitions and criteria for diabetic foot disease. Diabetes Metab Res Rev， 2020， 36 Suppl 1: e3268[2022-08-05]. https://doi.org/10.1002/dmrr.3268.

BANDYK D F. The diabetic foot: Pathophysiology, evaluation, and treatment. Semin Vasc Surg，2018，31(2/3/4): 43–48.

SINGH N， ARMSTRONG D G， LIPSKY B A. Preventing foot ulcers in patients with diabetes. JAMA，2005，293(2): 217–228.

LAVERY L A， ASHRY H R， VAN HOUTUM W， et al. Variation in the incidence and proportion of diabetes-related amputations in minorities. Diabetes Care，1996，19(1): 48–52.

ARMSTRONG D G， LAVERY L A， QUEBEDEAUX T L， et al. Surgical morbidity and the risk of amputation due to infected puncture wounds in diabetic versus nondiabetic adults. South Med J，1997，90(4): 384–389.

ARMSTRONG D G， LAVERY L A. Diabetic foot ulcers: prevention, diagnosis and classification. Am Fam Physician，1998，57(6): 1325–1332,1337-1338.

KANNEL W B， MCGEE D L. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care， 1979，2(2): 120–126.

PERNG C K， CHOU H Y， CHIU Y J. Identifying major predictors of lower-extremity amputation in patients with diabetic foot ulcers. J Chin Med Assoc，2021，84(3): 285–289.

RANA J S， NIEUWDORP M， JUKEMA J W， et al. Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes Metab，2007，9(3): 218–232.

PINTO A， TUTTOLOMONDO A， DI RAIMONDO D， et al. Cardiovascular risk profile and morbidity in subjects affected by type 2 diabetes mellitus with and without diabetic foot. Metabolism，2008，57(5): 676–682.

PINTO A， TUTTOLOMONDO A， DI RAIMONDO D， et al. Ischemic stroke in patients with diabetic foot. Int Angiol，2007，26(3): 266–269.

GOGALNICEANU P， LANCASTER R T， PATEL V I. Clinical Assessment of Peripheral Arterial Disease of the Lower Limbs. N Engl J Med， 2018， 378(18): e24[2022-08-05]. https://doi.org/10.1056/NEJMvcm1406358.

BARNES J A， EID M A， CREAGER M A， et al. Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease. Arterioscler Thromb Vasc Biol，2020，40(8): 1808–1817.

PAISEY R B， ABBOTT A， PAISEY C F， et al. Diabetic foot ulcer incidence and survival with improved diabetic foot services: An 18-year study. Diabet Med，2019，36(11): 1424–1430.

BUTT T， LILJA E， ELGZYRI T， et al. Amputation-free survival in patients with diabetic foot ulcer and peripheral arterial disease: Endovascular versus open surgery in a propensity score adjusted analysis. J Diabetes Complications，2020，34(5): 107551.

ELGZYRI T， LARSSON J， NYBERG P， et al. Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes. Eur J Vasc Endovasc Surg， 2014，48(4): 440–446.

SHABHAY A， HORUMPENDE P， SHABHAY Z， et al. Clinical profiles of diabetic foot ulcer patients undergoing major limb amputation at a tertiary care center in North-eastern Tanzania. BMC Surg，2021，21(1): 34.

WOLF G， MULLER N， BUSCH M， et al. Diabetic foot syndrome and renal function in type 1 and 2 diabetes mellitus show close association. Nephrol Dial Transplant，2009，24(6): 1896–1901.

LEWIS S， RAJ D， GUZMAN N J. Renal failure: Implications of chronic kidney disease in the management of the diabetic foot. Semin Vasc Surg， 2012，25(2): 82–88.

AKINCI B， YESIL S， BAYRAKTAR F， et al. The effect of creatinine clearance on the short-term outcome of neuropathic diabetic foot ulcers. Prim Care Diabetes，2010，4(3): 181–185.


Refbacks

  • There are currently no refbacks.